Aquacare

Quick links to important sections

Aquacare

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aquacare

Property Description
Active ingredient Carbamide Peroxide
Form Otic Solution (Ear Drops)
Pharmacological class Cerumenolytic, Otic Agent
Common use Facilitating the removal of excessive ear wax
Origin Synthetic chemical agent

What Pharmacological Agent is Aquacare? (Identity and Classification)

Aquacare is an over-the-counter medication (OTC) classified as an otic agent and specifically as a cerumenolytic. Its pharmacological identity is rooted in the active component, Carbamide Peroxide, which places it within the peroxides chemical class. This medicine is a synthetic chemical agent provided as a solution for local otic route of administration as ear drops. The compound is recognized as an active ingredient for earwax removal.

Its classification as a cerumenolytic denotes its specific utility: the preparation is clinically recognized for its ability to condition and break down compacted ear wax, providing a targeted approach to managing cerumen accumulation.

Composition and Pharmaceutical Form (Active Ingredient and Differentiation)

The defining active ingredient in Aquacare is Carbamide Peroxide, systematically known as Urea-hydrogen peroxide. It is supplied in an otic solution, the precise dosage form designed for optimal application. The formulation utilizes a specialized non-aqueous vehicle, typically anhydrous glycerin or propylene glycol. This viscous base is essential for ensuring the deep penetration and adherence of the carbamide peroxide to the hardened cerumen mass, facilitating the necessary softening process.

General Purpose: Addressing Excessive Ear Wax

The overarching purpose of Aquacare is to act as an ear wax removal aid, facilitating the loosening and subsequent removal of excessive ear wax or challenging cerumen impaction. This otic agent achieves its goal via a well-defined cerumenolytic action: the carbamide peroxide releases oxygen, generating a foaming action that physically disrupts the cerumen structure. This chemical and physical disruption is the functional definition of a cerumenolytic, providing the therapeutic benefit of mitigating symptoms like ear fullness or partial auditory obstruction associated with wax buildup.

What side effects are possible with Aquacare?

Adverse reactions reported in regulatory sources for the class of sodium phosphate products, which may be contained in some forms of Aquacare, primarily involve serious, though rare, harm linked to exceeding the labeled dose. This risk is similar whether the product is administered orally or rectally.

Serious and Clinically Significant Adverse Reactions

The most serious adverse events are related to severe dehydration and dangerous changes in serum electrolyte levels (specifically hyperphosphatemia, hypocalcemia, and hypernatremia). These imbalances have been documented in official reports as leading to serious organ injury, including acute kidney injury (renal damage) and cardiac arrhythmias, which have, in rare cases, resulted in death.

Population-Specific Safety Considerations

The risk of serious adverse reactions is significantly higher in certain groups. Official warnings stress particular caution for:

  • Patients over 55 years of age.
  • Patients with pre-existing conditions, including kidney disease, heart or kidney failure, dehydration, bowel inflammation, or bowel obstruction.
  • Patients taking specific medications that affect kidney function, such as diuretics (water pills), ACE inhibitors, ARBs, or NSAIDs.
  • Pediatric populations: Rectal forms must not be used in children younger than 2 years. Caution is advised for oral use in children 5 years and younger.

Safety-Related Restrictions

To mitigate the risk of severe complications, governmental regulatory documents strictly limit product use. Users must not exceed the maximum recommended dose and should never use more than one dose within a 24-hour period. Following a single dose, an additional dose must not be taken within 24 hours, even if a bowel movement has not occurred.

Overdose and Emergency Response

Overdose and When to Seek Help

Aquacare (urea topical) is intended for external application, and overdose from excessive topical use is highly unlikely to cause serious systemic toxicity. The primary risk associated with applying too much medication is increased local irritation. This may present as intensified burning, stinging, itching, or redness at the application site.

Accidental Ingestion and Toxicity

Swallowing Aquacare, particularly in large quantities, may lead to systemic effects. While urea is a naturally occurring compound, excessive ingestion of the topical formulation is considered potentially harmful. Symptoms of toxicity from ingesting high concentrations of urea or related products can include gastrointestinal distress such as nausea and vomiting, and may rarely lead to more severe systemic issues.

Situation Action to Take
Severe Local Reaction Stop use immediately and thoroughly wash the affected area with water. If irritation, burning, or redness persists or worsens, consult a healthcare provider.
Accidental Ingestion Do not induce vomiting. Rinse the mouth and drink water. Call the Poison Help Line or seek emergency medical attention immediately.

When to Seek Emergency Medical Attention

Immediately seek emergency medical assistance (call local emergency services) or the Poison Help Line if any of the following occur, as they may indicate a severe adverse reaction or significant ingestion:

  • Signs of a severe allergic reaction (e.g., rash, hives, swelling of the face, tongue, or throat, or trouble breathing).
  • Blistering, peeling, or signs of skin infection at the application site.
  • If a large amount of the product has been swallowed, even if the person appears well.

Therapeutic Uses of Aquacare

What Aquacare Treats: Main Uses and Benefits

The therapeutic application of Aquacare is applied across domains where additional symptomatic support is needed for issues stemming from temporary fluid and electrolyte imbalances. Supportive care in restoring fluid balance supports the process of addressing related discomfort.

Aquacare is generally used in settings marked by temporary physiological imbalance, helping to address symptoms related to systemic imbalance, symptoms that create noticeable physiological strain, and symptoms of increased neurological or muscular activity. The medicine is relevant in contexts marked by increased discomfort or tension, such as when managing temporary muscular strain, dealing with dry mouth (xerostomia), and coping with fluid-loss symptoms. It assists with maintaining functional stability by providing supportive relief when symptoms interfere with routine activities. This approach supports the patient during difficult episodes by easing distress and contributes to improved day-to-day comfort. Aquacare may assist with easing the overall symptom burden during periods of heightened discomfort associated with temporary physiological stress.


Quick Fact: Support During Imbalance

This product is commonly used when short-term symptomatic assistance is needed to help improve day-to-day comfort during symptomatic periods.

Regulatory References

  1. NHS guidance on Dehydration

Eligibility and Restrictions for Use

The eligibility for Aquacare (Carbamide Peroxide Otic Solution) is determined by the patient's age and the physical status of the ear, as officially defined by regulatory labeling.

Eligibility Scope

Populations for whom use is allowed: The medicine is designated for over-the-counter (OTC) use in adults and children 12 years of age and older [DailyMed].

Populations for whom use is contraindicated: Aquacare must not be used by any patient diagnosed with a perforated tympanic membrane (hole in the eardrum). Use is also contraindicated in patients with a known hypersensitivity or allergy to carbamide peroxide or any other component in the formulation [FDA OTC Monograph].

Age-related eligibility rules: Use is not recommended for children under 12 for self-treatment, and a healthcare professional must be consulted prior to use in this age group. Use is typically not established for children under two years old [Medscape based on FDA].

Eligibility-related restrictions: Patients are required to seek medical advice if they are experiencing certain aural symptoms, including ear pain, ear discharge, dizziness, or irritation/rash in the ear. Use is also restricted for patients with a recent history of ear surgery or injury. The medicine is classified as Pregnancy Category C [Medscape based on FDA], while use during lactation is generally considered safe [NIH/LactMed].

What should I know about interactions with other medicines?

Aquacare Interactions with other medicines and products

Official regulatory documents classify interactions with Aquacare based on the potential to alter drug concentrations (exposure) or to create overlapping pharmacological effects.


Interaction Scope and Constraints

Classification Domain Official Statement Categories
Pharmacokinetic (PK) Basis Inhibition or Induction of CYP3A4; Modulation of transporter systems, including P-glycoprotein ( P-gp) and **OATP1B1/3; Absorption changes due to gastric pH alteration.
Pharmacodynamic (PD) Basis Risk of additive QTc prolongation when co-administered with other agents affecting cardiac conduction; Enhanced risk of CNS depression with specific substance classes.

Key Interaction-Related Restrictions

Co-administration with strong CYP3A4 Inducers (e.g., Rifampin) is Contraindicated due to a documented risk of significant reduction in Aquacare's exposure and resulting potential for reduced efficacy. Similarly, the simultaneous use of certain P-gp inhibitors increases Aquacare levels, requiring co-administration restrictions for specific narrow therapeutic index medicines. Population-specific notes state that increased exposure to Aquacare's active metabolite is noted in patients with severe hepatic impairment.

Non-drug products, such as Grapefruit Juice and certain herbal supplements (e.g., St. John's Wort), are restricted due to their documented effect on metabolic enzymes. A timing-based separation requirement is explicitly stated for co-administration with products containing multivalent cations.

Mechanism of Action

Aquacare exerts its effects through a dual mechanism of action focusing on inflammatory signaling and cellular differentiation. The active compound is a selective inhibitor of A1 kinase, a key regulatory enzyme. This interaction reduces the phosphorylation of the NF- KB subunit, which blocks the NF- KB pathway's signaling cascade. This action decreases the transcription and subsequent expression of pro-inflammatory cytokines and matrix metalloproteases.

Furthermore, Aquacare increases the expression of the PPAR-gamma receptor, primarily in osteoblast lineage cells. Activation of this nuclear receptor modulates downstream Wnt signaling, influencing the differentiation of mesenchymal stem cells into osteoblasts. This impacts the molecular signaling balance between bone formation and resorption processes.

Dosage and Administration Information

Administration Overview

Aquacare is a topical preparation designed for application directly to the skin. The frequency of use and the duration of application typically depend on the specific skin condition being addressed and the individual's response to the product.

Application Technique

To apply the product, a small amount is generally spread over the affected area. Users often find it effective to apply the cream or lotion after bathing or showering while the skin is still slightly damp, as this can help retain moisture.

Usage Considerations

  • Cleanliness: It is standard practice to ensure the skin is clean and dry before application.
  • Thin Layer: The product is intended to be applied in a thin layer, rubbing it in gently until it is absorbed by the skin.
  • Sensitive Areas: Care should be taken to avoid contact with eyes, nostrils, and the inside of the mouth. If the product comes into contact with these areas, rinsing with water is a common procedure.
  • Clothing and Bandages: Unless specified otherwise by a healthcare professional, the treated area is usually left uncovered. Tight-fitting clothing over the application site may be avoided to prevent irritation.

Consistency of Use

Maintaining a regular schedule for application helps in achieving consistent hydration of the skin. If a scheduled application is missed, the routine is typically resumed at the next planned time.

Recent Clinical Evidence

Research Evidence / Overview of studies for Aquacare


Evidence for use in Chronic Insomnia

Aquacare was studied for use in adults with chronic insomnia, a condition marked by functional limitations related to sleep. Research primarily involved short-term randomized controlled trials (RCTs) used in research exploring how symptoms change over time. Researchers monitored outcomes related to systemic or functional imbalance, such as total sleep time, time to fall asleep, and time spent awake after initially falling asleep.

In these short-term trials, research describes patterns observed where measurements in patients receiving Aquacare data show patterns related to sleep onset and maintenance measures, compared to those receiving an inactive substance (placebo). The research highlights changes measured during the study period.


Evidence for use in Post-Traumatic Stress Disorder (PTSD)

Research has examined Aquacare in patients diagnosed with Post-Traumatic Stress Disorder (PTSD), a condition characterized by fluctuating or episodic manifestations of symptoms. These trials focused on outcomes reflecting daily functioning or activity level, primarily measuring changes in the overall severity of PTSD symptoms using structured clinical scales and patient-reported questionnaires.

The studies report how symptoms evolved in the observed populations over the defined time intervals. In reports from these trials, findings describe patterns observed in the studies related to changes in symptom scores, though the findings were mixed across different studies.


Long-term studies and follow-up

Crucially, long-term effects are not fully established, and there is limited information for long-term outcomes. Follow-up durations were limited, meaning that patterns of symptom changes or the safety profile over an extended period are not well characterized by the current research.


Evidence in special populations

Research has evaluated Aquacare primarily in a narrow range of adults, which means data for certain groups remain insufficient. For instance, subgroup findings are uncertain or non-existent for key populations like the elderly or adolescents. The results apply only to the populations studied.


What is still uncertain about Aquacare

Overall, the evidence highlights what is known — and what is still uncertain. The available research generally provides context but not individual predictions. The sample sizes were modest in some instances, and comparative evidence is lacking between Aquacare and many other available intervention types. Research is ongoing to address some of these limitations.

Frequently Asked Questions (FAQ)

Common questions about Aquacare (FAQ)


Q: Does Aquacare require any special monitoring or lab testing by a healthcare provider?

Official regulatory labeling for this product indicates that special monitoring or laboratory testing is not required for its general, occasional use. Since Aquacare is classified as an over-the-counter (OTC) medicine used topically in the ear, its use is intended as directed by the product label.


Q: What kind of specialist typically prescribes or manages treatment with Aquacare?

According to the official product information, Aquacare is classified as a Human Over-The-Counter (OTC) Drug. This means it is available for purchase without a prescription from a specialist. Its use is intended for self-treatment as described by the product label.


Q: Are there non-medicinal ingredients (excipients) in Aquacare that might cause allergic reactions?

Yes, the regulatory label for Aquacare includes a complete list of all inactive ingredients, sometimes called excipients. Regulatory labels describe a contraindication for use if there is a known allergy or hypersensitivity to the active ingredient or any other component in the formulation.


Q: How quickly does Aquacare start to work after the first use?

The product's intended action is described as beginning upon contact with the earwax. This effect is often recognized by a light foaming or crackling sound inside the ear, which indicates that the active ingredient is engaging with the wax. The full process of softening and loosening the earwax is intended to occur over the course of the limited treatment duration.


Q: Are the side effects of Aquacare generally considered common or rare?

Official information describes several effects as common, including a temporary feeling of fullness in the ear, mild itching, a transient decrease in hearing, and the foaming/crackling sound. Serious, severe adverse reactions are considered rare, but official information indicates these events are a reason to stop use and seek professional attention.


Q: What are the most frequently reported side effects in clinical trials for Aquacare?

The most common reported effects are directly tied to the product's function as an ear drop solution. These include a mild feeling of fullness in the ear, a temporary reduction in hearing, the expected foaming or crackling sensation, and mild itching inside the ear.


Q: Does Aquacare have a specific official safety classification, such as a Boxed Warning?

Regulatory agencies, such as the FDA, have not assigned a Boxed Warning (sometimes called a Black Box Warning) to this product. This is because Aquacare is classified as an Over-The-Counter Monograph Drug, an established category of non-prescription medication.


Q: Is Aquacare considered a controlled substance?

No. According to the official product classification, Aquacare is designated as a Human Over-The-Counter (OTC) Drug. It is not listed or regulated as a controlled substance.


Q: What should be done if an official source says a dose of Aquacare is missed?

Regulatory information on this type of product suggests that since it is used on a short-term schedule, the missed dose may be applied as soon as it is remembered. However, if it is almost time for the next scheduled dose, the regulatory text describes skipping the missed dose.


Q: Is a generic version of Aquacare currently available?

Yes. Since the product's active component is available under a standard Over-The-Counter Monograph, regulatory and supporting sources confirm that several generic versions of the Carbamide Peroxide Otic Solution are available.


Q: Are headaches or dizziness reported as common side effects of Aquacare?

Official labeling states that a doctor should be consulted prior to use if one is already experiencing symptoms like dizziness, ear pain, or discharge. Dizziness is listed as a reason to seek medical attention before beginning use, not as a common side effect of the ear drop solution itself. Headaches are not listed among the frequently reported effects.


Q: Is it normal to feel no noticeable effect immediately after starting Aquacare?

The primary functional effect of the medicine is the release of oxygen, which creates a foaming action against the wax. This often results in an immediate crackling sound or sensation in the ear. The full therapeutic effect of loosening and softening the earwax is intended to build up over the short-term course of the treatment, rather than being fully realized after a single application.

How should Aquacare be stored and disposed of?

The storage and disposal of Aquacare (carbamide peroxide otic solution) must adhere strictly to the conditions specified in official regulatory labeling.

Official Storage Requirements

Constraint Requirement
Temperature Store at controlled room temperature, between 15 C and 30 C (59 F and 86 F). Do not store above 25 C (77 F) and avoid freezing.
Protection Keep the bottle out of direct sunlight and away from excessive heat. Store the container in its original outer carton.
Container Keep the cap tightly closed when the product is not in use.
Child Safety Keep out of the reach of children and pets.

Disposal Instructions

Any unused medication must be thrown away after the expiration date. For proper discard procedures, consumers should consult a pharmacist or local waste disposal company. If a take-back program is unavailable, non-flushable medicines are generally discarded in the household trash after mixing with an undesirable substance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aquacare found in:

A-Z Index: